PFF Launches Drug Development Pipeline Tool
The Pulmonary Fibrosis Foundation (PFF) launched a new PF Drug Development Pipeline tool to help the pulmonary fibrosis (PF) community search for different treatment options currently in development for interstitial lung diseases.
Building off PFF’s Clinical Trials Education Center, the Pipeline tool features news about recent drug and study announcements, as well as links to relevant trials on the Clinical Trial Finder page to ensure patients are aware of opportunities to participate in clinical trials targeted at their specific conditions. The tool allows viewers to filter search results by study phase, disease/condition, intervention type and more.
In addition, users can access a Drug Development Pipeline Glossary to better understand the development process, and a user feedback form to share any questions or concerns they have with the tool to aid in future enhancements.
In addition, the PFF connects PF researchers to valuable medical information from more than 2,000 patient volunteers through the PFF Patient Registry. This research tool offers a combination of data from a wide range of patients, including those with less-studied forms of PF, to generate a resource for future research into treatments and provides data for improving and reassessing existing care guidelines.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The Role of Human Oversight With Artificial Intelligence in Clinical Research
April 12th 2024In the fifth and final part of this video interview with ACT editor Andy Studna, Stephen Pyke, chief clinical data and digital officer, Parexel, highlights the importance of human oversight when using artificial intelligence to aid in decision making.
